TITLE

HER2 Expression in Thyroid Tumors

AUTHOR(S)
Mondi, Matthew M.; Rich, Ryan; Ituarte, Phillip; Wong, Mariwil; Bergman, Simon; Clark, Orlo H.; Perrier, Nancy D.
PUB. DATE
December 2003
SOURCE
American Surgeon;Dec2003, Vol. 69 Issue 12, p1100
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Similarities exist in hormone receptors of breast, prostate, and thyroid tumors. HER2 oncogene expression is known to be present in breast and prostate tumors, but conflicting data have been published about its presence in thyroid tumors. This uncertainty prompted us to examine the incidence of HER2 overexpression in normal and malignant thyroid tissue. Normal and neoplastic thyroid tissue samples from 46 female and 9 male patients were assayed for HER2 expression by immunohistochemical assay. Of the 55 total samples, 36 were from neoplasms and 19 were from benign tissues. Significant HER2 overexpression was not found in any benign or malignant thyroid tissue. Two of 6 thyroid carcinomas from male patients showed 1+ reactivity for HER2 expression on immunohistochemistry assay, but remained negative on fluorescene in sito hybridization confirmatory testing. No significant expression of HER2 was noted in benign or malignant thyroid tissue. These results cast doubt on the value of HER2 as a prognostic factor or possible target for specific antitumor therapy for thyroid cancer.
ACCESSION #
11856136

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics